Repligen
RGEN
#2298
Rank
HK$65.02 B
Marketcap
HK$1,153
Share price
1.23%
Change (1 day)
18.85%
Change (1 year)
Categories

Repligen (RGEN) - Total debt

Total debt on the balance sheet as of March 2026 : HK$5.39 Billion

According to Repligen 's latest financial reports the company's total debt is HK$5.39 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Repligen - Total debt on balance sheet (from 2004 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$5.36 B0.76%
2024-12-31HK$5.32 B-4.17%
2023-12-31HK$5.55 B68.22%
2022-12-31HK$3.30 B15.78%
2021-12-31HK$2.85 B33.69%
2020-12-31HK$2.13 B4.11%
2019-12-31HK$2.05 B153.05%
2018-12-31HK$0.81 B4.51%
2017-12-31HK$0.77 B4.96%
2016-12-31HK$0.73 B
2005-03-31HK$0.93 M40.18%
2004-03-31HK$0.66 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
HK$499.71 B 9,168.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$338.42 B 6,176.87%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$158.99 B 2,848.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$364.04 B 6,651.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.19 B-96.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$2.31 B-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$3.18 B-40.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$2.27 B-57.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$11.28 B 109.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$23.96 B 344.47%๐Ÿ‡บ๐Ÿ‡ธ USA